Genedata Bioprocess at Ferring – A Lean and Smart Approach for Setting Up an Antibody Development Platform

Grégory Mouret, Upstream Process Scientist at the Ferring Biologics Innovation Center in Lausanne, Switzerland.

Learn how Ferring has implemented fully digitalized bioprocess development workflows. By connecting state-of-the art facilities with an end-to-end data backbone, Ferring has streamlined development operations and increased data quality across their globally operating antibody, gene therapy, and microbiome replacement therapy groups.

Having one central data platform ensures data quality, integrity, and traceability across cell line development, USP, DSP, and formulation groups and connects data generation, processing, and sharing at all Ferring R&D sites.

Learn how Ferring uses Genedata Bioprocess to:

• Increase operational efficiency within and across USP, DSP, CLD, and bioanalytical teams.
• Obtain new insights from diverse stages of process development by analyzing all data and leveraging instant access to information across sites.
• Enforce data quality, integrity, and compliance from early development through bioprocessing, and provide a source of structured CMC data for submission to regulatory agencies.
• Continuously optimize processes based on learnings from previous development campaigns.
• Directly integrate with instruments, inventory, and barcoding systems to automate two-way data transfer to protect data quality and integrity.